Core Viewpoint - AdaptHealth Corp. (AHCO) is currently viewed as a more attractive investment option compared to Haleon PLC Sponsored ADR (HLN) for value investors, based on various financial metrics and rankings [1][3][7]. Valuation Metrics - AHCO has a forward P/E ratio of 10.18, significantly lower than HLN's forward P/E of 19.71, indicating that AHCO may be undervalued [5]. - The PEG ratio for AHCO is 1.25, while HLN's PEG ratio stands at 2.72, suggesting that AHCO has a better balance between its price and expected earnings growth [5]. - AHCO's P/B ratio is 0.97, compared to HLN's P/B of 2.07, further supporting the notion that AHCO is undervalued relative to its book value [6]. Earnings Estimates - AHCO holds a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions, while HLN has a Zacks Rank of 4 (Sell), suggesting a less favorable earnings outlook [3][7]. - The stronger estimate revision activity for AHCO compared to HLN implies that AHCO's earnings outlook is improving more significantly [7]. Value Grades - AHCO has received a Value grade of A, while HLN has a Value grade of C, reflecting the overall better valuation metrics and earnings outlook for AHCO [6][7].
AHCO vs. HLN: Which Stock Is the Better Value Option?